Skip to main content
. 2020 Jul 28;35(30):e280. doi: 10.3346/jkms.2020.35.e280

Table 3. Clinical outcomes according to disease severity on admissiona .

Variables Overall (n = 2,710) Disease severity on admissionb
1–2 (n = 2,280) 3–4 (n = 130) 5–7 (n = 45)
Disease severity at illness day 14 (± 1 day)
Discharged 422/2,212 (19.1) 380/1,940 (19.6) 4/108 (3.7) 1/44 (2.3)
1–2 1,627/2,212 (73.5) 1,516/1,940 (78.1) 38/108 (35.2) 2/44 (4.6)
3–4 98/2,212 (2.3) 36/1,940 (1.8) 52/108 (48.2) 5/44 (11.4)
5–7 51/2,212 (2.3) 8/1,940 (0.4) 10/108 (9.3) 29/44 (65.9)
Death 14/2,212 (0.6) 0/1,940 (0.0) 4/108 (3.7) 7/44 (15.9)
Disease severity at illness day 28 (± 1 day)
Discharged 1,350/2,191 (61.6) 1,181/1,905 (62.0) 38/91 (41.8) 5/36 (13.9)
1–2 772/2,191 (35.2) 716/1,905 (37.6) 27/91 (29.7) 2/36 (5.6)
3–4 26/2,191 (1.2) 4/1,905 (0.2) 16/91 (17.6) 6/36 (16.7)
5–7 24/2,191 (1.1) 4/1,905 (0.2) 3/91 (3.3) 15/36 (41.7)
Death 19/2,191 (0.9) 0/1,905 (0.0) 7/91 (7.7) 8/36 (22.2)

Data are presented number (%).

ECMO = extracorporeal membrane oxygenation.

aPercentages may not total 100 because of rounding. Patients without a disease severity score on admission day (279, 9.1%) or died on admission day (2, 0.1%) were also excluded from this analysis; b1, no limitation of daily activities; 2, limitation of daily activities but no need for supplemental oxygen therapy; 3, need for supplemental oxygen therapy via nasal cannula; 4, need for supplemental oxygen therapy via facial mask; 5, need for high-flow supplemental oxygen therapy or non-invasive mechanical ventilation; 6, need for invasive mechanical ventilation; 7, multi-organ failure or need for ECMO therapy.